Background: Tuberculosis caused by Mycobacterium tuberculosis (M. tuberculosis), remains as one of the leading causes of deaths worldwide, with nearly two million death cases annually. BCG (Bacille Calmette-Guerin) continues to be the most widely used vaccine in the world, but the protective immunity differs in different parts of the world. Accordingly, new strategies including DNA vaccines are essentially needed. This study was aimed to design and construct a cloning vector containing mpt64 gene of M. tuberculosis. Materials and Methods: M. tuberculosis H37Rv was cultured on Lowenstein Jensen medium, and genomic DNA was extracted. The mpt64 gene was amplified by PCR using designed specific primers. After the digestion of mpt64 and pcDNA3.1 (+) by BamHI and EcoRI restriction enzymes, the mpt64 fragment was ligated into the digested vector using T4 DNA ligase enzyme. Then, the recombinant vector was transformed into competent Escherichia coli (E. coli) TOP10 strain. To confirm the colonies of transformed bacteria, antibiotic resistance, colony-PCR, restriction enzyme digestion and DNA sequencing were used. Results: To confirm the clones, colony-PCR using mpt64 specific primers was performed and the fragment of 718 bp was observed by gel electrophoresis. Clones were also verified by restriction enzyme digestion using BamHI and EcoRI restriction enzymes and the 718 bp fragment was observed. Furthermore, results of DNA sequencing showed 100% homology with the mpt64 fragment of H37Rv in GenBank. Conclusion: In this study, the mpt64 fragment was successfully cloned in pcDNA3.1 (+) vector. This construct can be used in future studies as a DNA vaccine in animal models to induce immune system responses.
This protein consists of 228 amino acids with molecular weight of 24.8 kDa that has superoxide dismutase and strong cellular immune activity (13, 14) . This study was aimed to design and construct a cloning vector containing mpt64 gene of M. tuberculosis strain H37Rv.
MATERIALS AND METHODS

DNA Extraction and Polymerase Chain Reaction
M. tuberculosis strain H37Rv was cultured on
Lowenstein Jensen (LJ) medium and was incubated for six weeks at 37˚C. DNA extraction was performed using boiling method (15) .
The mpt64 primers were designed by Gene Runner The DNA amplification involved initial denaturation at 95°C for 4 min, proceeded by 35 cycles of denaturation at 94°C for 30 sec, annealing at 60°C for 30 sec, extension at 72°C for 45 sec, followed by final extension at 72°C for seven minutes. Then, 100 μL of the PCR product was electrophoresed on 1% agarose gel and the mpt64 fragment purification was performed using AccuPrep® Gel Purification Kit (Bioneer, Korea).
Cloning of mpt64 fragment into pcDNA3.1 (+) vector
Both pcDNA3.1 (+) plasmid and PCR product were digested by BamHI and EcoRI restriction enzymes (Thermo 
RESULTS
In this study, we amplified M. tuberculosis strain H37Rv mpt64 gene by PCR method and fragment of 718 bp was observed by gel electrophoresis (Figure 1 ). After gel purification of PCR product, single and double digestions were performed on the product.
After digestion of PCR product by BamHI and EcoRI, the desired fragment was observed by gel electrophoresis.
The pcDNA3.1 (+) vector was also digested with both
BamHI and EcoRI and a band relating to 5428 bp was observed. Then, mpt64 fragment was ligated into the pcDNA3.1 (+) vector by T4 DNA ligase enzyme. The ligation product was used to transform E. coli TOP10 strain using cold 0.1 M CaCl2/ MgCl2 solution and transformed bacteria were cultured on ampicillin included LB agar.
Colony-PCR was performed using mpt64 specific primers to confirm insertion of our fragment into the vector and the 718 bp fragment was observed by gel electrophoresis.
Purification of recombinant vector was performed by
GeneJET Plasmid Miniprep Kit (Thermo Scientific, Germany) and the same fragment was observed in gel electrophoresis for the extracted plasmid PCR by mpt64 specific primers. Then the recombinant vector was subjected to double digestion with BamHI and EcoRI, so the insert cut out and was observed by gel electrophoresis.
Final confirmation was based on DNA sequencing of recombinant vector. Fan and colleagues showed that MPT64 could activate RAW264.7 macrophage to induce cytokines significantly (7) .
In this study, we cloned mpt64 fragment into the eukaryotic pcDNA3.1 (+) vector to be used as a DNA vaccine. In further studies, immunization can be considered as a DNA vaccine in laboratory animal models.
